Education
About Us
Working with TipRanks
Follow Us
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
BAFNAPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹67.80 - ₹94.80
Previous CloseN/A
Volume2.58K
Average Volume (3M)481.00
Market Cap
₹1.81B
Enterprise ValueN/A
Total Cash (Recent Filing)₹13.96M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)42.2
Beta0.33
Next Earnings
May 30, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)1.82
Shares Outstanding23,656,336
10 Day Avg. Volume701
30 Day Avg. Volume481
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.30
Price to Sales (P/S)0.00
P/FCF Ratio37.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BAFNAPH FAQ
What was Bafna Pharmaceuticals Limited’s price range in the past 12 months?
Bafna Pharmaceuticals Limited lowest stock price was ₹67.80 and its highest was ₹94.80 in the past 12 months.
What is Bafna Pharmaceuticals Limited’s market cap?
Bafna Pharmaceuticals Limited’s market cap is ₹1.81B.
When is Bafna Pharmaceuticals Limited’s upcoming earnings report date?
Bafna Pharmaceuticals Limited’s upcoming earnings report date is May 30, 2025 which is in 10 days.
How were Bafna Pharmaceuticals Limited’s earnings last quarter?
Bafna Pharmaceuticals Limited released its earnings results on Feb 06, 2025. The company reported ₹0.401 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.401.
Is Bafna Pharmaceuticals Limited overvalued?
According to Wall Street analysts Bafna Pharmaceuticals Limited’s price is currently Overvalued.
Does Bafna Pharmaceuticals Limited pay dividends?
Bafna Pharmaceuticals Limited pays a Notavailable dividend of ₹0.6 which represents an annual dividend yield of N/A. See more information on Bafna Pharmaceuticals Limited dividends here
What is Bafna Pharmaceuticals Limited’s EPS estimate?
Bafna Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bafna Pharmaceuticals Limited have?
Bafna Pharmaceuticals Limited has 23,656,336 shares outstanding.
What happened to Bafna Pharmaceuticals Limited’s price movement after its last earnings report?
Bafna Pharmaceuticals Limited reported an EPS of ₹0.401 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bafna Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:BAFNAPH
---
Technical Analysis
Alchemist Limited
―
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Sun Pharmaceutical Industries Limited
―
---